Drug recall · August 22, 2018
PRASH 12.2mcg/1.22m/19.29 recall
Why: Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
- Lots / codes
All lots within expiry
- Quantity
- 1 vial
- Company
- Ranier's Compounding Laboratory, Jeannette, PA
- Distribution
- Product was distributed within the state of Pennsylvania.
- Initiated
- July 25, 2018 · Voluntary: Firm initiated
- Classified
- August 15, 2018
- Reported
- August 22, 2018
- Ended
- September 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.